About
Technology
Issues
FAQ
Links
Official Page
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.